where are we in sequencing adcs in hr breast cancer?
Published 1 year ago • 294 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
0:44
adcs in early breast cancer
-
0:46
what does the future hold for adcs in breast cancer?
-
0:59
treatments for hr postmenopausal breast cancer
-
4:45
giredestrant plus palbociclib vs anastrozole plus palbociclib for post-menopausal, her2-negative...
-
3:33
aromatase inhibitors for breast cancer
-
28:31
virtual pink house: tamoxifen & aromatase inhibitors in er breast cancer
-
1:08
nicholas john shea, md
-
1:10
destiny-04: her2 1 /fish- metastatic breast cancer tdxd treatment | jane meisel, md | asco22 updates
-
1:04
data: anastrozole in patients with hr breast cancer following adjuvant tamoxifen
-
4:39
anastrozole duration for post-menopausal breast cancer patients after 5 years of endocrine therapy
-
0:52
dr. harvey on aromatase inhibitor treatment duration
-
0:50
dr. jagsi discusses the benefits of hypofractionated radiotherapy for breast cancer
-
2:20
escalation of adjuvant therapy in hr breast cancer
-
0:55
ha (hyaluronic acid) joint formula from purity products
-
2:36
ch news: st. joseph's healthcare hamilton's edap
-
2:21
adcs for the treatment of her2-low breast cancer
-
1:37
dr. han on the differences between cdk 4/6 inhibitors in er breast cancer
-
0:50
breast cancer | abus
-
2:51
breast cancer: extended adjuvant therapy and cost factors
-
1:04
dr. schenkein on ag-221 for the treatment of aml
-
1:05
dr. jean hoffman-censits on the results of a phase ii trial studying atezolizumab in bladder cancer